| Serial Number | 98123485 |
| Word Mark | REGENXBIO |
| Filing Date | Wednesday, August 9, 2023 |
| Status | 641 - NON-FINAL ACTION - MAILED |
| Status Date | Wednesday, April 17, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
| Goods and Services | Biotechnological platform technology, namely, biological nanoparticles, recombinant viruses, and adenoviruses for gene delivery to biological cells that includes recombinant adeno-associated viral (rAAV) vectors to provide a platform for specific expression of biologics with therapeutic effect in gene therapy, RNA interference (RNAi), and cell therapy |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, September 7, 2023 |
| Primary Code | 005 |
| First Use Anywhere Date | Monday, September 1, 2014 |
| First Use In Commerce Date | Monday, September 1, 2014 |
| Party Name | RegenxBio Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Rockville, US 20850 |
| Event Date | Event Description |
| Wednesday, April 10, 2024 | ASSIGNED TO EXAMINER |
| Wednesday, April 17, 2024 | NON-FINAL ACTION WRITTEN |
| Wednesday, April 17, 2024 | NON-FINAL ACTION E-MAILED |
| Wednesday, April 17, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Saturday, August 12, 2023 | NEW APPLICATION ENTERED |
| Thursday, September 7, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |